BIOLOGÍA

Sorry, this entry is only available in European Spanish.

28 February 2022

CIENCIA RESEARCH AND INNOVATION

Sorry, this entry is only available in European Spanish.

21 February 2022

BIOLOGÍA CIENCIA INNOVACIÓN RESEARCH AND INNOVATION TECNOLOGÍA

A research group from Harvard University (USA), in collaboration with teams from Emory University, has designed and built the first fully autonomous biohybrid fish made from human heart stem cells. This research, published in the journal Science, is a very important step in the scientific understanding of the biophysical principles that make the heart work....

14 February 2022

INNOVACIÓN

Sorry, this entry is only available in European Spanish.

7 February 2022

EXPLORACIÓN ESPACIAL RESEARCH AND INNOVATION

Sorry, this entry is only available in European Spanish.

31 January 2022

GENERAL

Sorry, this entry is only available in European Spanish.

25 January 2022

INNOVACIÓN TECNOLOGÍA

A scientific group from the University of Cambridge has developed a semi-automated insulin release system, known as an 'artificial pancreas', which substantially improves glycemic control in children between 1 and 7 years of age with type 1 diabetes without increasing hypoglycemia. The research, published in the New England Journal of Medicine, is the first to...

24 January 2022

BIOLOGÍA CIENCIA

Sorry, this entry is only available in European Spanish.

17 January 2022

BIOLOGÍA GENÓMICA RESEARCH AND INNOVATION

This operation, a pioneer in the field of medicine, has been carried out by a team of surgeons from the University of Maryland (USA). In it, the patient, David Bennett, 57, diagnosed with heart disease without treatment options through an ordinary transplant, received a heart transplant from a genetically modified pig. This achievement constitutes an...

11 January 2022

CIENCIA RESEARCH AND INNOVATION

The Hospital Clínic de Barcelona-IDIBAPS has developed a new CAR-T treatment for multiple myeloma, the second most common blood cancer, with encouraging results: "all patients improve, 75% of them maintain the response and not they have disease progression at 12 months, and 60% have complete remission without residual disease ", says Dr. Fernández de Larrea,...

20 December 2021

1 11 12 13 14 15 35